Symbol
MIST on Nasdaq
Investment type
Equity / Common Shares, no par value per share
Latest Disclosed Ownership
9.02M shares
Security Ownership
9.9%

Trails Edge Capital Partners, LP ownership in Milestone Pharmaceuticals Inc. Common Shares, no par value per share (MIST)

2025-11-14 - Trails Edge Capital Partners, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 9.02M shares of Milestone Pharmaceuticals Inc. Common Shares, no par value per share (MIST). This represents 9.9% percent ownership of the company. In their previous filing dated 2025-07-21, Trails Edge Capital Partners, LP had reported owning 8.85M shares, indicating an increase of 1.92% percent.